TABLE 2.
Combined results of subgroup analysis for HEI-2015 and risk of mortality (highest HEI-2015 vs. the lowest category)
| Outcome | Stratification criterion | Number of included studies (n) | Pooled HR (95% CI) | Heterogeneity |
|
|---|---|---|---|---|---|
| I2 (%) | P value∗ | ||||
| All-cause mortality | Gender | ||||
| Male | 5 | 0.84 (0.78, 0.89) | 83.8 | <0.001 | |
| Female | 8 | 0.78 (0.76,0.80) | 20.4 | 0.268 | |
| Region | |||||
| United States | 13 | 0.80 (0.79, 0.81) | 24.4 | 0.197 | |
| Non-United States | 3 | 0.90 (0.82, 0.98) | 0 | 0.613 | |
| Sample size | |||||
| <15,000 | 8 | 0.82 (0.77, 0.87) | 0 | 0.959 | |
| >15,000 | 9 | 0.81 (0.79, 0.83) | 62.6 | 0.006 | |
| Follow-up period | |||||
| <15 y | 10 | 0.83 (0.81, 0.86) | 27.9 | 0.188 | |
| ≥15 y | 7 | 0.8 (0.79, 0.81) | 0 | 0.476 | |
| Cancer-cause mortality | Gender | ||||
| Male | 2 | 0.79 (0.75, 0.82) | 0 | 0.587 | |
| Female | 5 | 0.82 (0.78, 0.85) | 0 | 0.798 | |
| Region | |||||
| United States | 9 | 0.8 (0.78, 0.83) | 0 | 0.792 | |
| Non-United States | 2 | 0.83 (0.69, 0.97) | 0 | 0.364 | |
| Sample size | |||||
| <15,000 | 3 | 0.89 (0.71, 1.07) | 0 | 0.793 | |
| >15,000 | 9 | 0.8 (0.78, 0.83) | 0 | 0.772 | |
| Follow-up period | |||||
| <15 y | 6 | 0.85 (0.79, 0.90) | 0 | 0.954 | |
| ≥15 y | 6 | 0.8 (0.77, 0.82) | 0 | 0.701 | |
| CVD-cause mortality | |||||
| Gender | |||||
| Male | 3 | 0.82 (0.72, 0.94) | 81.3 | 0.005 | |
| Female | 4 | 0.80 (0.73, 0.87) | 57.5 | 0.07 | |
Abbreviations: CI, confidence interval; CVD, cardiovascular disease; HEI, Healthy Eating Index; HR, hazard ratio.
P value for heterogeneity within each subgroup.